When to Intervene for Subclinical Cushing's Syndrome

被引：6

作者：

Hsieh, Lily B. ^{[1
]}

Mackinney, Erin ^{[2
]}

Wang, Tracy S. ^{[3
]}

机构：

[1] Med Coll Wisconsin, Div Surg Oncol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA

[2] Southern Illinois Univ, Sch Med, Dept Gen Surg, POB 19638, Springfield, IL 62794 USA

[3] Med Coll Wisconsin, Div Surg Oncol, Sect Endocrine Surg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA

来源：

SURGICAL CLINICS OF NORTH AMERICA | 2019年 / 99卷 / 04期

基金：

美国国家卫生研究院;

关键词：

Subclinical Cushing's syndrome; Adrenal incidentaloma; Minimally invasive adrenalectomy; Subclinical hypercortisolism; Subclinical glucocorticoid hypersecretion; NIGHT SALIVARY CORTISOL; URINE FREE CORTISOL; ADRENAL INCIDENTALOMAS; FOLLOW-UP; VERTEBRAL FRACTURES; CARDIOVASCULAR RISK; NATURAL-HISTORY; SINGLE-UNIT; DIAGNOSIS; HYPERCORTISOLISM;

D O I：

10.1016/j.suc.2019.04.011

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Without the overt clinical signs and symptoms associated with Cushing's syndrome, the diagnosis of subclinical Cushing's syndrome (SCS) is primarily based on biochemical evaluation. Despite being labeled as "subclinical," SCS is associated with significant morbidity that can be improved with adrenalectomy. Minimally invasive adrenalectomy is associated with low morbidity in the hands of experienced adrenal surgeons and is recommended as the treatment of choice for SCS patients with SCS-associated comorbidities.

引用

页码：747 / +

页数：13

共 55 条

[1] [Anonymous], 2002, NIH Consensus and State-of-the-Science Statements, V19, P1
[2] Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis
Bancos, Irina
Alahdab, Fares
Crowley, Rachel K.
Chortis, Vasileios
Delivanis, Danae A.
Erickson, Dana
Natt, Neena
Terzolo, Massimo
Arlt, Wiebke
Young, William F., Jr.
Murad, M. Hassan
[J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 175 (06) : R283 - R295
[3] Prevalence and natural history of adrenal incidentalomas
Barzon, L
Sonino, N
Fallo, F
Palù, G
Boscaro, M
[J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 149 (04) : 273 - 285
[4] Risk factors and long-term follow-up of adrenal incidentalomas
Barzon, L
Scaroni, C
Sonino, N
Fallo, F
Paoletta, A
Boscaro, M
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) : 520 - 526
[5] Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas
Bernini, GP
Moretti, A
Oriandini, C
Bardini, M
Taurino, C
Salvetti, A
[J]. BRITISH JOURNAL OF CANCER, 2005, 92 (06) : 1104 - 1109
[6] LATE-NIGHT SALIVARY CORTISOL FOR THE DIAGNOSIS OF CUSHING SYNDROME: A META-ANALYSIS
Carroll, Ty
Raff, Hershel
Findling, James W.
[J]. ENDOCRINE PRACTICE, 2009, 15 (04) : 335 - 342
[7] The diagnosis of Cushing's syndrome
Carroll, Ty B.
Findling, James W.
[J]. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2010, 11 (02) : 147 - 153
[8] Endogenous subclinical hypercortisolism and bone: a clinical review
Chiodini, I.
Vainicher, C. Eller
Morelli, V.
Palmieri, S.
Cairoli, E.
Salcuni, A. S.
Copetti, M.
Scillitani, A.
[J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 175 (06) : R265 - R282
[9] Bone loss rate in adrenal incidentalomas: A longitudinal study
Chiodini, I
Torlontano, M
Carnevale, V
Guglielmi, G
Cammisa, M
Trischitta, V
Scillitani, A
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) : 5337 - 5341
[10] Six controversial issues on subclinical Cushing's syndrome
Chiodini, Iacopo
Albani, Adriana
Ambrogio, Alberto Giacinto
Campo, Michela
De Martino, Maria Cristina
Marcelli, Giorgia
Morelli, Valentina
Zampetti, Benedetta
Colao, Annamaria
Pivonello, Rosario
[J]. ENDOCRINE, 2017, 56 (02) : 262 - 266

← 1 2 3 4 5 6 →